Plasmapheresis Market Forecast, Trend

Analysis & Competition Tracking - Global

Review 2017 to 2026

Healthcare
170 Pages
Published : Dec 2017
 Description
According to Fact.MR, the global plasmapheresis market is expected to represent a value of over
US$ 1,500 Mn by the end of 2026.

Prevalence of autoimmune diseases has led to an upsurge in demand for plasmapheresis globally.
Growing need for conducting an extracorporeal therapy is further expected to impact growth of
the global autoimmune diseases market positively. Some of the autoimmune diseases that
increasingly fuel demand for plasmapheresis include type 1 diabetes, celiac disease, rheumatoid
arthritis, temporal arteritis and lupus. In a recently published report, CDC stated that 9.4% of the
population in the U.S. have diabetes, and 30.3 million globally. Plasmapheresis is also used for
treatment of various forms of neurotherapy and sickle cell diseases.

Browse Full Report With TOC

Treatment of the Autoimmune Diseases to Boost Demand
Increasing prevalence of various autoimmune diseases will continue to fuel demand for extracorporeal
therapies globally. Occurrence of autoimmune disorders such as lupus can significantly damage various organs
such as lungs, kidney, heart, skin and joints. Adoption of plasmapheresis removes putative pathogenic
autoantibodies and circulates the immune complexes from the blood of patients with systematic lupus
erythematosus. Manufacturers in the healthcare industry are increasingly integrating various technological
advancements and innovative features in the plasmapheresis instruments such as apheresis machines in order
to offer enhanced instruments for conducting plasmapheresis globally. Bound to these factors, the global
plasmapheresis market is expected to witness significant growth during the forecast period.
Research for Biopharmaceutical Applications to Impact Global Market Growth
Demand for plasmapheresis also continues to remain high bound to growing need for donation. Growing need
for plasma to treat various disorders such as anaemia, stomach disease, blood loss, cancer, burns, childbirth
and heart diseases has led to surge in demand for the donation of the blood products. Moreover, blood
products donated are also used for the production of biopharmaceutical medications through the process of
fractionation. Biopharmaceutical companies are also increasingly investing in the research and development
for production of various medications. Surge in demand for biopharmaceutical medications for the treatment
of neuroendocrine tumors, diabetes, cancer and arthritis is further expected to fuel demand for
plasmapheresis globally. Moreover, growing need for donating blood products and producing
biopharmaceutical products has led to an increasing demand for the plasmapheresis in the global market. Such
factors will continue to impact growth of the global plasmapheresis market during positively.
 Table Of Contents
1. Global Outlook
2. Global Plasmapheresis Market - Executive Summary
3. Global Plasmapheresis Market Overview
3.1. Introduction
3.1.1. Global Plasmapheresis Market Taxonomy
3.1.2. Global Plasmapheresis Market Definition
3.2. Global Plasmapheresis Market Size (US$ Mn) and Forecast, 2012-2026
3.2.1. Global Plasmapheresis Market Y-o-Y Growth
3.3. Global Plasmapheresis Market Dynamics
3.4. Supply Chain
3.5. Cost Structure
3.6. Average Reduction of Plasma Constituents
3.7. Strategic Framework among Key Players of the Plasmapheresis Market
3.8. PESTL Analysis
3.9. Product Lifecycle
3.10. Patents
3.11. List of Distributors
3.12. Approvals
3.13. Key Participants Market Presence (Intensity Map) By Region
 4. Global Plasmapheresis Market Analysis and Forecast 2012-2026
4.1. Global Plasmapheresis Market Size and Forecast By Product Type, 2012-2026
4.1.1. Instruments Market Size and Forecast, 2012-2026
4.1.1.1. Revenue (US$ Mn) Comparison, By Region
4.1.1.2. Market Share Comparison, By Region
4.1.1.3. Y-o-Y growth Comparison, By Region
4.1.2. Disposables Market Size and Forecast, 2012-2026
4.1.2.1. Revenue (US$ Mn) Comparison, By Region
4.1.2.2. Market Share Comparison, By Region
4.1.2.3. Y-o-Y growth Comparison, By Region
4.2. Global Plasmapheresis Market Size and Forecast By End User, 2012-2026
4.2.1. Biopharmaceutical Companies Market Size and Forecast, 2012-2026
4.2.1.1. Revenue (US$ Mn) Comparison, By Region
4.2.1.2. Market Share Comparison, By Region
4.2.1.3. Y-o-Y growth Comparison, By Region
4.2.2. Hospitals & Clinics Market Size and Forecast, 2012-2026
4.2.2.1. Revenue (US$ Mn) Comparison, By Region
4.2.2.2. Market Share Comparison, By Region
4.2.2.3. Y-o-Y growth Comparison, By Region
4.2.3. Other End Users Market Size and Forecast, 2012-2026
4.2.3.1. Revenue (US$ Mn) Comparison, By Region
4.2.3.2. Market Share Comparison, By Region
4.2.3.3. Y-o-Y growth Comparison, By Region
 4.3. Global Plasmapheresis Market Size and Forecast By Application, 2012-2026
4.3.1. Therapeutic Plasmapheresis Market Size and Forecast, 2012-2026
4.3.1.1. Revenue (US$ Mn) Comparison, By Region
4.3.1.2. Market Share Comparison, By Region
4.3.1.3. Y-o-Y growth Comparison, By Region
4.3.2. Source Plasma Collection Market Size and Forecast, 2012-2026
4.3.2.1. Revenue (US$ Mn) Comparison, By Region
4.3.2.2. Market Share Comparison, By Region
4.3.2.3. Y-o-Y growth Comparison, By Region
4.4. Global Plasmapheresis Market Size and Forecast By Technology, 2012-2026
4.4.1. Membrane Filtration Market Size and Forecast, 2012-2026
4.4.1.1. Revenue (US$ Mn) Comparison, By Region
4.4.1.2. Market Share Comparison, By Region
4.4.1.3. Y-o-Y growth Comparison, By Region
4.4.2. Centrifugation Market Size and Forecast, 2012-2026
4.4.2.1. Revenue (US$ Mn) Comparison, By Region
4.4.2.2. Market Share Comparison, By Region
4.4.2.3. Y-o-Y growth Comparison, By Region
5. North America Plasmapheresis Market Size and Forecast, 2012-2026
5.1. North America Outlook
5.2. North America Parent Market Outlook
5.3. North America Target Market Outlook
5.4. Revenue (US$ Mn) Comparison, By Country
 5.4.1. US Market Size and Forecast (US$ Mn), 2012-2026
5.4.2. Canada Market Size and Forecast (US$ Mn), 2012-2026
5.5. Revenue (US$ Mn) Comparison, By Product Type
5.6. Revenue (US$ Mn) Comparison, By End User
5.7. Revenue (US$ Mn) Comparison, By Application
5.8. Revenue (US$ Mn) Comparison, By Technology
6. Latin America Plasmapheresis Market Size and Forecast, 2012-2026
6.1. Latin America Outlook
6.2. Latin America Parent Market Outlook
6.3. Latin America Target Market Outlook
6.4. Revenue (US$ Mn) Comparison, By Country
6.4.1. Brazil Market Size and Forecast (US$ Mn), 2012-2026
6.4.2. Mexico Market Size and Forecast (US$ Mn), 2012-2026
6.4.3. Rest of Latin America Market Size and Forecast (US$ Mn), 2012-2026
6.5. Revenue (US$ Mn) Comparison, By Product Type
6.6. Revenue (US$ Mn) Comparison, By End User
6.7. Revenue (US$ Mn) Comparison, By Application
6.8. Revenue (US$ Mn) Comparison, By Technology
7. Europe Plasmapheresis Market Size and Forecast, 2012-2026
7.1. Europe Outlook
7.2. Europe Parent Market Outlook
7.3. Europe Target Market Outlook
 7.4. Revenue (US$ Mn) Comparison, By Country
7.4.1. Germany Market Size and Forecast (US$ Mn), 2012-2026
7.4.2. UK Market Size and Forecast (US$ Mn), 2012-2026
7.4.3. France Market Size and Forecast (US$ Mn), 2012-2026
7.4.4. Spain Market Size and Forecast (US$ Mn), 2012-2026
7.4.5. Italy Market Size and Forecast (US$ Mn), 2012-2026
7.4.6. Nordic Market Size and Forecast (US$ Mn), 2012-2026
7.5. Revenue (US$ Mn) Comparison, By Product Type
7.6. Revenue (US$ Mn) Comparison, By End User
7.7. Revenue (US$ Mn) Comparison, By Application
7.8. Revenue (US$ Mn) Comparison, By Technology
8. Japan Plasmapheresis Market Size and Forecast, 2012-2026
8.1. Japan Outlook
8.2. Japan Parent Market Outlook
8.3. Japan Target Market Outlook
8.4. Revenue (US$ Mn) Comparison, By Country
8.4.1. Japan Market Size and Forecast (US$ Mn), 2012-2026
8.5. Revenue (US$ Mn) Comparison, By Product Type
8.6. Revenue (US$ Mn) Comparison, By End User
8.7. Revenue (US$ Mn) Comparison, By Application
8.8. Revenue (US$ Mn) Comparison, By Technology
9. MEA Plasmapheresis Market Size and Forecast, 2012-2026
9.1. MEA Outlook
9.2. MEA Parent Market Outlook
9.3. MEA Target Market Outlook
9.4. Revenue (US$ Mn) Comparison, By Country
9.4.1. GCC Countries Market Size and Forecast (US$ Mn), 2012-2026
9.4.2. South Africa Market Size and Forecast (US$ Mn), 2012-2026
9.4.3. Israel Market Size and Forecast (US$ Mn), 2012-2026
9.4.4. Rest of MEA Market Size and Forecast (US$ Mn), 2012-2026
9.5. Revenue (US$ Mn) Comparison, By Product Type
9.6. Revenue (US$ Mn) Comparison, By End User
9.7. Revenue (US$ Mn) Comparison, By Application
9.8. Revenue (US$ Mn) Comparison, By Technology
10. Global Plasmapheresis Market Company Share, Competition Landscape and Company Profiles
10.1. Company Share Analysis
10.2. Competition Landscape
10.3. Company Profiles
10.3.1. Haemonetics Corporation
10.3.2. Asahi Kasei Kuraray Medical Co, Ltd.
10.3.3. Terumo Corporation
10.3.4. B. Braun Melsungen AG
10.3.5. Baxter International Inc.
10.3.6. Fresenius SE & Co. KGaA
10.3.7. Kawasumi Laboratories, Inc.
10.3.8. Kaneka corporation
11. Research Methodology
12. Secondary and Primary Sources
13. Assumptions and Acronyms
14. Disclaimer
Request Free Sample Report
 Want Tailor-made Report?
Enquire at sales@factmr.com Now!

Get In Touch

Suite 9884
27 Upper Pembroke Street,
Dublin 2, Ireland
Toll Free : +353-1-6111-593
Email : sales@factmr.com
Website: https://www.factmr.com/

11